Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark B Leick

Showing results (1-10 of 53) with videos related to

Pageof 6
Sort By:
Blood|November 20, 2025
A pooled primate screen finds that MYD88-CD40 boosts CAR-TMark B Leick
The New England Journal of Medicine|August 20, 2020
TelephoneMark B Leick
Blood Advances|June 26, 2026
Navigating clinical decision-making for IEC-enterocolitisViktoria Blumenberg, Mark B Leick
American Journal of Hematology|January 12, 2019
CAR-T cells beyond CD19, UnCAR-Ted territoryMark B Leick, Marcela V Maus
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 15, 2025
Isolated oral CAR<sup>+</sup> T cell lymphoma after tisagenlecleucelMark B Leick, Marcela V Maus
Nature Reviews. Clinical Oncology|February 15, 2023
Multiomics STEP up in correlative analysis of response to CAR T cellsMark B Leick, Marcela V Maus
Best Practice & Research. Clinical Haematology|June 19, 2018
Toxicities associated with immunotherapies for hematologic malignanciesMark B Leick, Marcela V Maus
Current Hematologic Malignancy Reports|April 20, 2017
The Future of Targeting FLT3 Activation in AMLMark B Leick, Mark J Levis
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 1, 2020
Clinical Perspective: Treatment of Aggressive B Cell Lymphomas with FDA-Approved CAR-T Cell TherapiesMark B Leick, Marcela V Maus, Matthew J Frigault
The New England Journal of Medicine|November 14, 2019
Case 35-2019: A 66-Year-Old Man with Pancytopenia and RashMarcela V Maus, Mark B Leick, Kristine M Cornejo, et al.
Pageof 6

Showing results (1-10 of 53) with videos related to

Sort By:
Pageof 6
Blood|November 20, 2025
A pooled primate screen finds that MYD88-CD40 boosts CAR-TMark B Leick
The New England Journal of Medicine|August 20, 2020
TelephoneMark B Leick
Blood Advances|June 26, 2026
Navigating clinical decision-making for IEC-enterocolitisViktoria Blumenberg, Mark B Leick
American Journal of Hematology|January 12, 2019
CAR-T cells beyond CD19, UnCAR-Ted territoryMark B Leick, Marcela V Maus
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 15, 2025
Isolated oral CAR<sup>+</sup> T cell lymphoma after tisagenlecleucelMark B Leick, Marcela V Maus
Nature Reviews. Clinical Oncology|February 15, 2023
Multiomics STEP up in correlative analysis of response to CAR T cellsMark B Leick, Marcela V Maus
Best Practice & Research. Clinical Haematology|June 19, 2018
Toxicities associated with immunotherapies for hematologic malignanciesMark B Leick, Marcela V Maus
Current Hematologic Malignancy Reports|April 20, 2017
The Future of Targeting FLT3 Activation in AMLMark B Leick, Mark J Levis
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 1, 2020
Clinical Perspective: Treatment of Aggressive B Cell Lymphomas with FDA-Approved CAR-T Cell TherapiesMark B Leick, Marcela V Maus, Matthew J Frigault
The New England Journal of Medicine|November 14, 2019
Case 35-2019: A 66-Year-Old Man with Pancytopenia and RashMarcela V Maus, Mark B Leick, Kristine M Cornejo, et al.
Pageof 6